You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

AbstractFullPdf
Nov 2020306306133
Dec 2020607607237
Jan 2021253253122
Feb 2021224224124
Mar 2021246246107
Apr 202116316385
May 202115315376
Jun 2021141140106
Jul 202112712746
Aug 202114414475
Sep 2021162162111
Oct 2021233233126
Nov 202115315296
Dec 202111111357
Jan 202212714062
Feb 202212613470
Mar 202219420879
Apr 202215016394
May 202214515274
Jun 202213514386
Jul 2022102111109
Aug 20229610380
Sep 2022100105175
Oct 202212112579
Nov 202212913272
Dec 202211111162
Jan 202310110152
Feb 202313913946
Mar 2023909367
Apr 2023686840
May 2023798138
Jun 2023737432
Jul 2023868744
Aug 2023686842
Sep 2023909139
Oct 2023888838
Nov 202311111349
Dec 2023959545
Jan 2024818239
Feb 2024888941
Mar 20248587117
Total590160063272